secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001528287-25-000030
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace reports record Q3 revenue $27.4M (+30% YoY); raises FY2025 guidance
-----------------------------------------------------------------------------

- Record quarterly revenue of $27.4M, up 30% YoY; RNS System revenue $22.6M (+31% YoY).
- Gross margin expanded to 77.4% from 73.2% YoY; operating loss narrowed to $2.6M from $4.2M.
- Net loss improved to $3.5M from $5.5M YoY; cash and short-term investments $60M.
- Raised FY2025 revenue guidance to $97M-$98M (21-23% YoY growth) and gross margin to 76%-77%.
- On track to submit NAUTILUS PMA supplement to FDA for IGE indication expansion by year-end 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000152828725000030/0001528287-25-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000152828725000030/npce-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001528287-25-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer